198 related articles for article (PubMed ID: 28385910)
1. Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways.
Sarmento-Cabral A; L-López F; Gahete MD; Castaño JP; Luque RM
Mol Cancer Res; 2017 Jul; 15(7):862-874. PubMed ID: 28385910
[TBL] [Abstract][Full Text] [Related]
2. Obesity and metabolic dysfunction severely influence prostate cell function: role of insulin and IGF1.
L-López F; Sarmento-Cabral A; Herrero-Aguayo V; Gahete MD; Castaño JP; Luque RM
J Cell Mol Med; 2017 Sep; 21(9):1893-1904. PubMed ID: 28244645
[TBL] [Abstract][Full Text] [Related]
3. A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling.
Huang M; Narita S; Numakura K; Tsuruta H; Saito M; Inoue T; Horikawa Y; Tsuchiya N; Habuchi T
Prostate; 2012 Dec; 72(16):1779-88. PubMed ID: 22514016
[TBL] [Abstract][Full Text] [Related]
4. Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer.
Colquhoun AJ; Venier NA; Vandersluis AD; Besla R; Sugar LM; Kiss A; Fleshner NE; Pollak M; Klotz LH; Venkateswaran V
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):346-52. PubMed ID: 22614062
[TBL] [Abstract][Full Text] [Related]
5. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model.
Mavropoulos JC; Buschemeyer WC; Tewari AK; Rokhfeld D; Pollak M; Zhao Y; Febbo PG; Cohen P; Hwang D; Devi G; Demark-Wahnefried W; Westman EC; Peterson BL; Pizzo SV; Freedland SJ
Cancer Prev Res (Phila); 2009 Jun; 2(6):557-65. PubMed ID: 19470786
[TBL] [Abstract][Full Text] [Related]
6. Prostate tumor growth is impaired by CtBP1 depletion in high-fat diet-fed mice.
Moiola CP; De Luca P; Zalazar F; Cotignola J; Rodríguez-Seguí SA; Gardner K; Meiss R; Vallecorsa P; Pignataro O; Mazza O; Vazquez ES; De Siervi A
Clin Cancer Res; 2014 Aug; 20(15):4086-95. PubMed ID: 24842953
[TBL] [Abstract][Full Text] [Related]
7. Metformin combined with quercetin synergistically repressed prostate cancer cells via inhibition of VEGF/PI3K/Akt signaling pathway.
Sun S; Gong F; Liu P; Miao Q
Gene; 2018 Jul; 664():50-57. PubMed ID: 29678660
[TBL] [Abstract][Full Text] [Related]
8. Strong antineoplastic effects of metformin in preclinical models of liver carcinogenesis.
Cauchy F; Mebarki M; Leporq B; Laouirem S; Albuquerque M; Lambert S; Bourgoin P; Soubrane O; Van Beers BE; Faivre S; Bedossa P; Paradis V
Clin Sci (Lond); 2017 Jan; 131(1):27-36. PubMed ID: 27803295
[TBL] [Abstract][Full Text] [Related]
9. High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling.
Hayashi T; Fujita K; Nojima S; Hayashi Y; Nakano K; Ishizuya Y; Wang C; Yamamoto Y; Kinouchi T; Matsuzaki K; Jingushi K; Kato T; Kawashima A; Nagahara A; Ujike T; Uemura M; Pena MDCR; Gordetsky JB; Morii E; Tsujikawa K; Netto GJ; Nonomura N
Clin Cancer Res; 2018 Sep; 24(17):4309-4318. PubMed ID: 29776955
[No Abstract] [Full Text] [Related]
10. Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis.
Narita S; Tsuchiya N; Saito M; Inoue T; Kumazawa T; Yuasa T; Nakamura A; Habuchi T
Prostate; 2008 Feb; 68(3):321-35. PubMed ID: 18175332
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of the tumor promoter gene wip1 induces insulin resistance.
Armata HL; Chamberland S; Watts L; Ko HJ; Lee Y; Jung DY; Kim JK; Sluss HK
Mol Endocrinol; 2015 Jan; 29(1):28-39. PubMed ID: 25379953
[TBL] [Abstract][Full Text] [Related]
12. Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression.
Huang M; Narita S; Inoue T; Tsuchiya N; Satoh S; Nanjo H; Sasaki T; Habuchi T
Endocr Relat Cancer; 2014 Feb; 21(1):39-50. PubMed ID: 24344250
[TBL] [Abstract][Full Text] [Related]
13. The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth
Tran LNK; Kichenadasse G; Morel KL; Lavranos TC; Klebe S; Lower KM; Ormsby RJ; Elliot DJ; Sykes PJ
In Vivo; 2019; 33(1):99-108. PubMed ID: 30587609
[TBL] [Abstract][Full Text] [Related]
14. Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
Park J; Kim WG; Zhao L; Enomoto K; Willingham M; Cheng SY
Oncotarget; 2016 Jun; 7(23):34832-44. PubMed ID: 27145454
[TBL] [Abstract][Full Text] [Related]
15. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
[TBL] [Abstract][Full Text] [Related]
16. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.
Venkateswaran V; Haddad AQ; Fleshner NE; Fan R; Sugar LM; Nam R; Klotz LH; Pollak M
J Natl Cancer Inst; 2007 Dec; 99(23):1793-800. PubMed ID: 18042933
[TBL] [Abstract][Full Text] [Related]
17. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
18. Metformin decreases high-fat diet-induced renal injury by regulating the expression of adipokines and the renal AMP-activated protein kinase/acetyl-CoA carboxylase pathway in mice.
Kim D; Lee JE; Jung YJ; Lee AS; Lee S; Park SK; Kim SH; Park BH; Kim W; Kang KP
Int J Mol Med; 2013 Dec; 32(6):1293-302. PubMed ID: 24068196
[TBL] [Abstract][Full Text] [Related]
19. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
[TBL] [Abstract][Full Text] [Related]
20. Effect of isocaloric low-fat diet on human LAPC-4 prostate cancer xenografts in severe combined immunodeficient mice and the insulin-like growth factor axis.
Ngo TH; Barnard RJ; Cohen P; Freedland S; Tran C; deGregorio F; Elshimali YI; Heber D; Aronson WJ
Clin Cancer Res; 2003 Jul; 9(7):2734-43. PubMed ID: 12855654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
